Novartis AG
AZA-QUINOLINE COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
Provided aza-quinoline compounds of Formula (I), pharmaceutical compositions comprising such compounds; and the use of such compounds for treating a disease or condition mediate by Enhancer of Zeste Homolog 2 (EZH2), Polycomb Repressive Complex 2 (PRC2), or a combination thereof.
Status:
Application
Type:
Utility
Filling date:
24 Sep 2020
Issue date:
8 Sep 2022